Inhaled lysine-aspirin as a bronchoprovocation procedure in aspirin-sensitive asthma: Its repeatability, absence of a late-phase reaction, and the role of histamine
- 1 August 1989
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 84 (2) , 232-241
- https://doi.org/10.1016/0091-6749(89)90330-8
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Bronchial hyperreactivity to histamine in aspirin sensitive asthmatics: relationship to aspirin threshold and effect of aspirin desensitisation.Thorax, 1985
- Grand rounds: Adverse reactions to wineJournal of Allergy and Clinical Immunology, 1985
- Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugsJournal of Allergy and Clinical Immunology, 1984
- Asthma and Anti-inflammatory Drugs Mechanisms and Clinical PatternsDrugs, 1983
- 232 Plasma mediator studies in aspirin sensitive asthma: Lack of a role for the mast cellJournal of Allergy and Clinical Immunology, 1983
- Aspirin-sensitive asthma: Tolerance to aspirin after positive oral aspirin challengesJournal of Allergy and Clinical Immunology, 1980
- An Analysis of the Role of IgE in Intolerance to Aspirin and TartrazineAllergy, 1978
- Inhibition of aspirin-induced bronchoconstriction by sodium cromoglycate inhalation.Thorax, 1977
- Refractory period to aspirin in a patient with aspirin-induced asthmaJournal of Allergy and Clinical Immunology, 1976
- Immunologic studies on aspirin: Clinical studies with aspiryl-protein conjugatesJournal of Allergy, 1970